WOL 3D is engaged in the business of providing 3D Printing solutions enabling easier prototyping finding its application in various sectors like manufacturing, education, engineering, architecture, interior designing, fashion designing, product designing, medical, dental etc.WOL 3D IPO is set to raise Rs 25.56 crores. The issue is a combination of fresh issue of ₹21.78 Cr and offer for sale of 2 ₹3.78 Cr.
IPO opens
September 23, 2024
IPO Closes
September 25, 2024
IPO Size (Rs.)
₹25.56 Cr
Breakup
Fresh issue ₹21.78 Cr + OFS ₹3.78 Cr
Face Value:
₹ 10
IPO Price in Rs :
₹142 to ₹150 per share
Minimum Lot
1000 Shares
Listing At
NSE SME
NII Quota
~50%
Retail Quota
~50%
Lead Manager
Hem Securities Limited
Registrar
Bigshare Services
Market maker
Hem Finlease
About WOL3D India
WOL3D India Limited, established in 2019, provides 3D printing solutions.
They cater to sectors like manufacturing, education, engineering, architecture, and healthcare.
Their offerings include 3D printers, scanners, pens, filaments, and prototyping services using FDM, SLA, and SLS technologies.
They distribute international 3D printer brands and manufacture their own filaments.
With a presence in multiple cities through branches and franchises, they also operate 3D Printing Experience Centers.
The promoters of the Company are Rahul Virendra Chandalia, Saloni Rahul Chandalia, Pradeep Shripal Jain and Swati Pradeep Jain.
Financials: , WOL 3D India
Particulars (Rs. Cr.)
2024
2023
2022
Total Income
4,001.43
2,371.32
2,037.03
Profit after tax
503.3
240.56
84.42
Equity Share Capital
300
300
100
Net worth
1061.22
566.8
326.25
Net Asset Value
21.22
11.34
6.52
Total Borrowings
572.6
678.98
509.78
Post issue Share Capital
645.2
FV
10.0
IPO price
150.0
EPS Fy23
3.7
PE Fy23
40.2
EPS Fy24
7.8
PE Fy24
19.2
Market cap in Lacs
9,678
Market cap / Sales
2.42
WOL 3D India IPO: Anchors
, WOL 3D India IPO: Salient Points
3D Printing is used for additive manufacturing (AM) which is a computer-controlled process that creates three dimensional objects by depositing materials, usually in layers.
The potential of AM is growing very rapidly, and the global value of the industry has increased from US$1.71 Bn in 2011 to US$ 13.8 Bn in 2019, a rate of more than 25% per year since 1989. The 5-year growth outlook for these technologies’ averages to 23.5% per annum, almost doubling every three years.
Manufactures high-quality thermoplastic filaments using ABS and PLA plastics for 3D printers.
Manufacturing facility in Bhiwandi, Maharashtra, WOL 3D has branch offices and franchisee locations across various Indian cities.
Products are sold through experience center, branch offices, e-commerce platforms commerce platforms such as Flipkart , Jiomart, Firstcry, Indiamart, Snapdeal, Moglix and Amazon Seller Services or through retail chains outlets like CROMA and Crosswords.
Net proceeds use :
Purpose
Rs. crores (%)
Repayment of Outstanding Borrowings
3 (13.77%)
Funding for Working Capital Requirements
14.50 (66.55%)
General Corporate Purpose
4.28 (19.68%)
Clients
Company was aired at Show Shark tank Season 2 which got good recognition and awareness of company’s products.
I may not be able to apply in WOL 3D India IPO due to shortage of funds, else would have bid for the IPO. Performance of company has been steady. Additive manufacturing (AM) has good potential.
GMP as reported on social media is Rs. 65 (43%)
Lead manager Hem Securities Limited has quite decent record and enjoys good standing.
SME IPOs are quite volatile and new retail investors need to exercise considerable caution in my view.
This post is exploratory and educational purposes only. Please do your own diligence before investing in SME IPOs like this.
Standard disclaimer: I am not a SEBI registered analyst and above analysis is for educational purpose only. Iam a postgraduate in engineering & Management . I have in the past cleared some exams like NISM-Series-V-A: Mutual Fund Distributors Certification, NISM-Series-X-A: Investment Adviser (Level 1) Certification and NISM-Series-X-B: Investment Adviser (Level 2) Examination. This post is my view on the subject matter and is only academic and exploratory in nature. It is not meant to influence investment decisions of investors. I may have bias/vested interest in covered Stock/Mutual Funds/NCD etc. due to my own investment or leaning. Further my understanding of the areas on which I write may be imperfect or incomplete and data could be wrong due to limited time and resources at my disposal. Do check the data from company’s RHP and exchanges before making any decision. Please do your own due diligence as stock market/MF investments have high degree of inherent risk.